Myopia Incidence Among Premature Infants with Type-2 ROP and Without ROP: A Single Center Retrospective Cohort Study
DOI:
https://doi.org/10.63682/jns.v14i32S.7970Keywords:
Retinopathy of Prematurity type 2, Premature Baby, Myopia, Birth weight, Gestational Age, Oxygen SupplementationAbstract
Introduction: Retinopathy of prematurity (ROP) arises from the atypical development of retinal blood vessels in infants born prematurely. These infants face an increased likelihood of developing myopia, particularly those diagnosed with ROP. The occurrence and intensity of myopia in this population are associated with various factors, including low birth weight, the degree of prematurity, the severity of ROP, and the treatments administered for the condition. Purpose: This study aims to compare the incidence of myopia and examine the relationship between risk factors (birth weight, gestational age, oxygen use) and myopia in premature infants with Type 2 ROP and those without ROP at Dr. Soetomo General Hospital, Surabaya. Methods: This analytical observational study used a retrospective cohort design. All premature infants meeting the inclusion criteria from medical records between January 2017 and December 2022 were included. Visual acuity was assessed using Grating Acuity and Cycloplegic Examinations, and myopia was evaluated at 12 months using streak retinoscopy. Results: Among 67 preterm infants, 34 (50.7%) did not develop ROP, while 33 (49.3%) had Type 2 ROP. Most infants had a birth weight between 1500-2000 grams (43.3%) and a gestational age over 32 weeks (55.2%). Oxygen use was recorded in 39 infants (58.2%). Most infants did not develop myopia, with 62.7% in the left eye and 67.2% in the right eye. A notable difference in the incidence of myopia was observed between infants with Type 2 ROP and those without, with statistical significance (p = 0.002). In contrast, factors such as birth weight, gestational age, and oxygen therapy showed no significant association with myopia in either group. Conclusion: Preterm infants without ROP exhibited a lower rate of myopia compared to those with Type 2 ROP. The lack of correlation with common risk factors implies that impaired anterior segment development may contribute to the onset of myopia.
Downloads
Metrics
References
Achiron, R., Kreiser, D., & Achiron, A. (2000). Axial growth of the fetal eye and evaluation of the hyaloid artery: in utero ultrasonographic study. Prenatal Diagnosis, 20(11), 894–899.
Al Oum, M., Donati, S., Cerri, L., Agosti, M., & Azzolini, C. (2014). Ocular alignment and refraction in preterm children at 1 and 6 years old. Clinical Ophthalmology, 1263–1268.
Chen, C., & Zhang, Q.-S. (2013). Advances in medical care for extremely low birth weight infants worldwide. Zhongguo Dang Dai Er Ke Za Zhi Chinese Journal of Contemporary Pediatrics, 15(8), 703–707.
Courtright, P., Hutchinson, A. K., & Lewallen, S. (2011). Visual impairment in children in middle- and lower income countries. Archives of Disease in Childhood, 96(12), 1129–1134.
Dikopf, M. S., Machen, L. A., Hallak, J. A., Chau, F. Y., & Kassem, I. S. (2019). Zone of retinal vascularization and refractive error in premature eyes with and without spontaneously regressed retinopathy of prematurity. Journal of American Association for Pediatric Ophthalmology and Strabismus, 23(4), 211-e1.
Gursoy, H., Basmak, H., Bilgin, B., Erol, N., & Colak, E. (2014). The effects of mild-to-severe retinopathy of prematurity on the development of refractive errors and strabismus. Strabismus, 22(2), 68–73.
Kaya, M., Berk, A. T., & Yaman, A. (2018). Long-term evaluation of refractive changes in eyes of preterm children: a 6-year follow-up study. International Ophthalmology, 38, 1681–1688.
Korkmaz, L., Karaca, C., Akin, M. A., Bastug, O., Sahiner, M., Ozdemir, A., Gunes, T., Ozturk, M. A., & Kurtoglu, S. (2018). Short-term refractive effects of propranolol hydrochloride prophylaxis on retinopathy of prematurity in very preterm newborns. Current Eye Research, 43(2), 213–217.
NABABAN, A. R. O. Y., Loebis, R., & Prastyani, R. (2023). RELATIONSHIP OF GESTATION AGE AND WEIGHT IN PREMATURE BIRTH WITH RETINOPATHY OF PREMATURITY IN A TERTIER HOSPITAL: Oral Presentation-Observational Study-Ophthalmologist. Ophthalmologica Indonesiana, 49(S2).
Ouyang, L.-J., Yin, Z.-Q., Ke, N., Chen, X.-K., Liu, Q., Fang, J., Chen, L., Chen, X.-R., Shi, H., & Tang, L. (2015). Refractive status and optical components of premature babies with or without retinopathy of prematurity at 3-4 years old. International Journal of Clinical and Experimental Medicine, 8(7), 11854.
Quinn, G. E., Dobson, V., Davitt, B. V, Wallace, D. K., Hardy, R. J., Tung, B., Lai, D., Good, W. V, & Group, E. T. for R. of P. C. (2013). Progression of myopia and high myopia in the Early Treatment for Retinopathy of Prematurity study: findings at 4 to 6 years of age. Journal of American Association for Pediatric Ophthalmology and Strabismus, 17(2), 124–128.
Ruan, L., Shan, H.-D., Liu, X.-Z., & Huang, X. (2015). Refractive status of Chinese with laser-treated retinopathy of prematurity. Optometry and Vision Science, 92(4S), S3–S9.
Stephenson, T., Wright, S., O’Connor, A., Fielder, A., Johnson, A., Ratib, S., & Tobin, M. (2007). Children born weighing less than 1701 g: visual and cognitive outcomes at 11–14 years. Archives of Disease in Childhood-Fetal and Neonatal Edition, 92(4), F265–F270.
Wilkinson, A. R., Haines, L., Head, K., & Fielder, A. R. (2008). UK retinopathy of prematurity guideline. Early Human Development, 84(2), 71–74.
Xie, X., Wang, Y., Zhao, R., Yang, J., Zhu, X., Ouyang, L., Liu, M., Chen, X., Ke, N., & Li, Y. (2022). Refractive status and optical components in premature infants with and without retinopathy of prematurity: a 4-to 5-year cohort study. Frontiers in Pediatrics, 10, 922303.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.